Renal Denervation for Hypertension

被引:64
|
作者
Bertog, Stefan C. [1 ,2 ]
Sobotka, Paul A. [3 ,4 ]
Sievert, Horst [1 ]
机构
[1] Cardiovasc Ctr Frankfurt, D-60389 Frankfurt, Germany
[2] Vet Affairs Med Ctr, Dept Cardiol, Minneapolis, MN USA
[3] Medtronic Inc, Minneapolis, MN USA
[4] Ohio State Univ, Columbus, OH 43210 USA
关键词
hypertension; renal denervation; sympathetic nervous system; SYMPATHETIC-NERVE ACTIVITY; BAROREFLEX ACTIVATION THERAPY; CONGESTIVE-HEART-FAILURE; OBSTRUCTIVE SLEEP-APNEA; RESISTANT HYPERTENSION; TRANSPLANT RECIPIENTS; NOREPINEPHRINE; PLASMA; KIDNEY; INNERVATION;
D O I
10.1016/j.jcin.2011.12.011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Systemic hypertension is a major burden to the individual and society. Its association with major adverse cardiac and cerebral events and favorable effects of antihypertensive therapy are undisputed. However, despite multidrug therapy, blood pressures are frequently suboptimally controlled. Moreover, adverse drug effects often interfere with patients' lifestyles and affect compliance. Therefore, alternative treatment strategies have been explored. Most recently, attention has been redirected to the sympathetic nervous system (SNS) in the pathogenesis of hypertension. In addition, interruption of the renal SNS in humans with resistant hypertension has been studied with promising results. The following review provides an overview of the anatomy and physiology of the renal SNS, the rational for manipulating the SNS, and the results of therapeutic renal sympathetic denervation. (J Am Coll Cardiol Intv 2012;5:249-58) (C) 2012 by the American College of Cardiology Foundation
引用
收藏
页码:249 / 258
页数:10
相关论文
共 50 条
  • [41] Renal Denervation Prevents Cholinergic Mediated Hypertension and Renal Macrophage Infiltration
    Harwani, Sailesh C.
    Raikwar, Nandita S.
    Ratcliff, Jason A.
    Allamargot, Chantal
    Chapleau, Mark W.
    Abboud, Francois M.
    CIRCULATION, 2017, 136
  • [42] Renal denervation: ready for prime time?
    Naehle, C. P.
    Schild, H.
    Wilhelm, K.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2013, 138 (43) : 2212 - 2218
  • [43] Expert consensus: Renal denervation for the treatment of arterial hypertension
    Pathak, Atul
    Girerd, Xavier
    Azizi, Michel
    Benamer, Hakim
    Halimi, Jean-Michel
    Lantelme, Pierre
    Lefevre, Thierry
    Sapoval, Marc
    ARCHIVES OF CARDIOVASCULAR DISEASES, 2012, 105 (6-7) : 386 - 393
  • [44] Renal denervation as therapy for hypertension: potentials and unanswered questions
    Vink, Eva E.
    Bots, Michiel L.
    Blankestijn, Peter J.
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2013, 20 (06) : 980 - 991
  • [45] An Update on the Role of Renal Artery Denervation in the Treatment of Hypertension
    Mewaldt, Christian
    Crawford, Emily
    Cluett, Jennifer
    Arvanitis, Lorenzo, V
    Kentoffio, Katie
    Secemsky, Eric A.
    Krawisz, Anna K.
    CURRENT TREATMENT OPTIONS IN CARDIOVASCULAR MEDICINE, 2024, 27 (01)
  • [46] Renal denervation for uncontrolled hypertension: critical review of the evidence
    Chen, Chongjia
    Upadhyay, Ashish
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2017, 26 (02) : 114 - 122
  • [47] Renal Denervation in High-risk Patients with Hypertension
    Heradien, Marshall J.
    van der Bijl, Pieter
    Brink, Paul A.
    HEART INTERNATIONAL, 2019, 13 (02): : 12 - 16
  • [48] Renal denervation: a key approach to hypertension and cardiovascular disease
    Shinohara, Keisuke
    HYPERTENSION RESEARCH, 2024, 47 (10) : 2671 - 2677
  • [49] Resistant hypertension: integration between pharmacotherapy and renal denervation
    Gallo, Giovanna
    GIORNALE ITALIANO DI CARDIOLOGIA, 2022, 23 (12) : 19S - 22S
  • [50] Sympathetic Pathophysiology in Hypertension Origins: The Path to Renal Denervation
    Esler, Murray D.
    Osborn, John W.
    Schlaich, Markus P.
    HYPERTENSION, 2024, 81 (06) : 1194 - 1205